期刊文献+

妊娠滋养细胞肿瘤180例临床疗效分析 被引量:4

Analysis on the clinical efficacy of 180 cases with gestational trophoblastic tumor
原文传递
导出
摘要 目的:分析滋养细胞肿瘤的规范化治疗及效果。方法:对1990~2008年收治的180例滋养细胞肿瘤患者的临床资料进行回顾性分析。结果:180例滋养细胞肿瘤患者平均年龄为31.8岁,126例患者行单纯化疗,54例患者行化疗加手术治疗。75例绒毛膜上皮癌的治愈率是79.45%,105例侵蚀性葡萄胎的治愈率是90.47%。结论:滋养细胞肿瘤患者首次化疗规范、足量并坚持巩固化疗,合理选择手术时机是影响滋养细胞肿瘤预后的重要因素。 Objective:To analyze the standard therapy and efficacy of gestational trophoblastic tumor. Methods:The clinical data of 180 patients with gestational trophoblastic tumor who were treated in the hospital from 1990 to 2008 were analyzed retrospectively. Results:The average age of 180 patients with gestational trophoblastic tumor was 31.8 years,126 patients were treated with simple chemotherapy,while the other 54 patients were treated with chemotherapy plus surgery.The curative rate of 105 patients with invasive hydatidiform mole was 90.47%. Conclusion:The important effect factors of prognosis of patients with gestational trophoblastic tumor are standard and insistent primary chemotherapy with full dose and reasonable surgical opportunity.
出处 《中国妇幼保健》 CAS 北大核心 2011年第30期4665-4667,共3页 Maternal and Child Health Care of China
关键词 妊娠 滋养细胞肿瘤 化疗 Pregnancy Gestational trophoblastic tumor Chemotherapy
  • 相关文献

参考文献10

二级参考文献29

  • 1崔竹梅,杨秀玉,向阳,宋鸿钊,邵丽娜,李大兵.足月产后绒癌误诊分析[J].中国妇产科临床杂志,2001,2(1):22-24. 被引量:8
  • 2冷金花,杨秀玉,杨宁,宋鸿钊,岳天孚.选择性盆腔动脉插管化疗致附壁血栓形成[J].中华妇产科杂志,1995,30(4):218-221. 被引量:10
  • 3杨秀玉,宋鸿钊.滋养细胞疾病诊断与治疗中的问题及对策[J].中华妇产科杂志,1996,31(4):195-198. 被引量:49
  • 4Kohorn El. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease : description and critical assessment[J]. Int J Gynecol Cancer, 2001,11 ( 1 ) :73-77.
  • 5Kohom El, Goldstein DP, Hancock BW, et al. Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasia. Report of the working committee of the international society for the study of trophoblastic disease and the International Gynecologic Cancer Society[ J]. Int J Gynecol Cancer. 2000.10( 1 ) :84-88.
  • 6杨秀玉 向阳 宋鸿钊 等.耐药及危重绒癌病例治疗的研究[J].中国医学科学院中国协和医科大学年鉴,2000,78:91-92.
  • 7Bagshawe KD. Treatment of high-risk choriocarcinoma. J Reprod Med, 1984,29:813-820.
  • 8DiSaia PJ, Creasman WT. Clinical gynecological oncology. 6th ed. Louis: Mosby Inc, 2002. 621-624.
  • 9Newlands ES, Bagshawe KD, Begent RH, et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol, 1991,98:550-557.
  • 10Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol,2000,18:854-859.

共引文献68

同被引文献37

  • 1张俊巧,张卫珍.宫腔化疗在恶性滋养细胞肿瘤治疗中的应用[J].河北医药,2006,28(2):114-114. 被引量:1
  • 2杨隽钧,向阳,万希润,杨秀玉.恶性滋养细胞肿瘤的疗效和预后因素分析[J].现代妇产科进展,2006,15(11):816-821. 被引量:5
  • 3李文敏.2种化疗方案治疗绒毛膜癌的经济学评价[J].中国药房,2007,18(23):1769-1770. 被引量:4
  • 4Palmer JE,Hancock BW,Tidy JA.Influence of age as a factor in the outcome of gestational trophoblastic neoplasia[J].J Reprod M ed,2008,53(8):565-574.
  • 5Salehi S,Eloranta S,Johansson AL,et al.Reporting and incidence trends of hydatidiform mole in Sw eden 1973-2004[J].Acta Oncol,2011,50(3):367-372.
  • 6Braun-Parvez L,Charlin E,Caillard S,et al.Gestationalchoriocarcinoma transmission follow ing multiorgan donation[J].Am J Transplant,2010,10(11):2541-2546.
  • 7Chalouhi GE,Golfier F,Soignon P,et al.Methotrexate for2000 FIGO low-risk gestational trophoblastic neoplasia patients:efficacy and toxicity[J].Am J Obstet Gynecol,2009,200(6):643,e1-e6.
  • 8Bianconi MI,Otero S,Moscheni O,et al.Gestational trophoblastic disease:a 21-year review of the clinical experience at an Argentinean public hospital[J].J Reprod M ed,2012,57(7-8):341-349.
  • 9Nagy B,Molnar J,Rovo L,et al.Effective chemoradiotherapy w ithout additive toxicity in locoregionally advanced head and neck cancer[J].Anticancer Res,2003,23(5):4329-4332.
  • 10Feng F,Xiang Y.Surgical management of chemotherapy-resistant gestational trophoblastic neoplasia[J].Expert Rev Anticancer,2010,10(1):71-80.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部